Immunocore Holdings (IMCR) Retained Earnings (2019 - 2026)

Immunocore Holdings has disclosed Retained Earnings across 8 years of filings, most recently posting -$818.3 million for Q1 2026.

• Retained Earnings for Q1 2026 came in at -$818.3 million, down 3.49% year-over-year; the trailing twelve-month figure through Mar 2026 was -$818.3 million (down 3.49% YoY), and the FY2025 annual result was -$831.3 million, down 4.46% from the prior year.
• Retained Earnings came in at -$818.3 million for Q1 2026 at Immunocore Holdings, up from -$831.3 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $396.3 million in Q4 2022 to a low of -$831.3 million in Q4 2025.
• The 5-year median for Retained Earnings is -$780.7 million (2024), against an average of -$414.0 million.
• Across the five-year window, Retained Earnings surged 161.07% in 2022 and tumbled 2136.0% in 2025, its largest moves.
• Immunocore Holdings' Retained Earnings stood at $396.3 million in 2022, then plunged by 109.15% to -$36.3 million in 2023, then sank by 2094.54% to -$795.8 million in 2024, then fell by 4.46% to -$831.3 million in 2025, then rose by 1.56% to -$818.3 million in 2026.
• The last three Retained Earnings figures came in at -$818.3 million (Q1 2026), -$831.3 million (Q4 2025), and -$30.0 million (Q3 2025), per Business Quant data.